Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07002294 · ClinicalTrials.gov registry record · NA
The Effect of SPecialty cAre on Recovery From Cardiac Arrest Trial (the SPARC Trial)
A NA study, sponsored by University of Pittsburgh.
- Not yet
- Registry status
- NA
- Development phase
- 1,618
- Enrollment target
NCT07002294: Clinical Trial NA study, sponsored by University of Pittsburgh.
NCT07002294 is a NA study that has not yet begun recruiting, run by University of Pittsburgh. The registered enrollment target is 1,618 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07002294, a NA study, has not yet begun recruiting, sponsored by University of Pittsburgh.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,618 participants
- Enrollment target
Study Summary
This randomized clinical trial will determine if adult participants who are in the emergency department after being resuscitated from a cardiac arrest outside of the hospital benefit from care delivered at specialized centers. The main question that it will answer is whether transferring participants to a hospital with a specialized cardiac arrest service improves recovery of function after 90 days. Participants will receive all usual medical care, but some participants will be offered transfer to a regional cardiac arrest center and others will be offered care at the closest appropriate hospital. Investigators will interview participants after 90 days to assess their recovery.
Primary Outcome
The Modified Rankin Scale (mRS) is a measure of functional recovery, measured 90 days after cardiac arrest. A Modified Rankin Score (mRS) of 0 corresponds to full functional recovery and a Modified Rankin Score (mRS) of 6 corresponds to death, with progressively worse functional outcomes at higher scores. Intermediate values reflect progressive functional dependence, with higher scores reflecting greater dependence on others.
Interventions
- OTHER Usual care
- OTHER Transfer to specialty care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,618 participants |
| Start Date | 2026-06 |
| Est. Completion | 2032-01 |
| Phase | NA |
What is known before NCT07002294 opens enrollment
NCT07002294 is an interventional study that assigns participants to a tested intervention. Its 1,618 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% higher).
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT07002294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07002294 about?
NCT07002294 is a clinical study titled "The Effect of SPecialty cAre on Recovery From Cardiac Arrest Trial (the SPARC Trial)". This randomized clinical trial will determine if adult participants who are in the emergency department after being resuscitated from a cardiac arrest outside of the hospital benefit from care delivered at specialized centers. The main question that it will answer is whether transferring participan...
What is the current status of trial NCT07002294?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,618 participants. The study started on 2026-06. Estimated completion is 2032-01.
What interventions are being tested in trial NCT07002294?
The interventions under investigation include: Usual care (OTHER), Transfer to specialty care (OTHER).
Who is sponsoring clinical trial NCT07002294?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07002294's enrollment target sits among peer trials
1,618 63rd of 2000 higher than 1,938 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia